NCT00270374View on ClinicalTrials.gov

A Study Comparing Blood Flow and Clinical and Safety Effects of the Addition of Natrecor (Nesiritide), Placebo or Intravenous Nitroglycerin to Standard Care for the Treatment of Worsening Congestive Heart Failure.

PHASE3CompletedINTERVENTIONAL
Enrollment

498

Participants

Timeline

Start Date

October 31, 1999

Study Completion Date

August 31, 2000

Conditions
Symptomatic Decompensated Congestive Heart FailureCongestive Heart Failure in Acute Coronary Syndrome
Interventions
DRUG

nesiritide

All Listed Sponsors
lead

Scios, Inc.

INDUSTRY

NCT00270374 - A Study Comparing Blood Flow and Clinical and Safety Effects of the Addition of Natrecor (Nesiritide), Placebo or Intravenous Nitroglycerin to Standard Care for the Treatment of Worsening Congestive Heart Failure. | Biotech Hunter | Biotech Hunter